These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1676900)

  • 1. Detection of tyrosine hydroxylase mRNA and minimal neuroblastoma cells by the reverse transcription-polymerase chain reaction.
    Naito H; Kuzumaki N; Uchino J; Kobayashi R; Shikano T; Ishikawa Y; Matsumoto S
    Eur J Cancer; 1991; 27(6):762-5. PubMed ID: 1676900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Supersensitive detection of tyrosine hydroxylase mRNA and neuroblastoma cells by reverse transcription and polymerase chain reaction].
    Naito H
    Hokkaido Igaku Zasshi; 1991 Mar; 66(2):135-41. PubMed ID: 1676393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase-polymerase chain reaction for tyrosine hydroxylase mRNA.
    Miyajima Y; Kato K; Numata S; Kudo K; Horibe K
    Cancer; 1995 Jun; 75(11):2757-61. PubMed ID: 7743482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow.
    Träger C; Kogner P; Lindskog M; Ponthan F; Kullman A; Kågedal B
    Clin Chem; 2003 Jan; 49(1):104-12. PubMed ID: 12507966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the PGP9.5 and tyrosine hydroxylase mRNAs for minimal residual neuroblastoma cells in bone marrow and peripheral blood.
    Yanagisawa TY; Sasahara Y; Fujie H; Ohashi Y; Minegishi M; Itano M; Morita S; Tsuchiya S; Hayashi Y; Ohi R; Konno T
    Tohoku J Exp Med; 1998 Mar; 184(3):229-40. PubMed ID: 9591338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology.
    Pagani A; Macri L; Faulkner LB; Tintori V; Paoli A; Garaventa A; Bussolati G
    Diagn Mol Pathol; 2002 Jun; 11(2):98-106. PubMed ID: 12045713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two methods for evaluating bone marrow metastasis of neuroblastoma: Reverse transcription-polymerase chain reaction for tyrosine hydroxylase and magnetic resonance imaging.
    Takemoto C; Nishiuchi R; Endo C; Oda M; Seino Y
    Pediatr Int; 2004 Aug; 46(4):387-93. PubMed ID: 15310300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma.
    Pession A; Libri V; Sartini R; Conforti R; Magrini E; Bernardi L; Fronza R; Olivotto E; Prete A; Tonelli R; Paolucci G
    Oncol Rep; 2003; 10(2):357-62. PubMed ID: 12579272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of neuroblastoma cells in bone marrow and peripheral blood by different techniques: accuracy and relationship with clinical features of patients.
    Corrias MV; Faulkner LB; Pistorio A; Rosanda C; Callea F; Piccolo MS; Scaruffi P; Marchi C; Lacitignola L; Occhino M; Gambini C; Tonini GP; Haupt R; De Bernardi B; Pistoia V; Garaventa A
    Clin Cancer Res; 2004 Dec; 10(23):7978-85. PubMed ID: 15585633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.
    Burchill SA; Bradbury FM; Smith B; Lewis IJ; Selby P
    Int J Cancer; 1994 Jun; 57(5):671-5. PubMed ID: 7910809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study.
    Fukuda M; Miyajima Y; Miyashita Y; Horibe K
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):10-3. PubMed ID: 11196262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early clinical evaluation of neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA.
    Burchill SA; Bradbury FM; Selby P; Lewis IJ
    Eur J Cancer; 1995; 31A(4):553-6. PubMed ID: 7576966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma.
    Lambooy LH; Gidding CE; van den Heuvel LP; Hulsbergen-van de Kaa CA; Ligtenberg M; Bökkerink JP; De Abreu RA
    Clin Cancer Res; 2003 Feb; 9(2):812-9. PubMed ID: 12576454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of tyrosine hydroxylase mRNA for diagnosis and detection of minimal residual disease in neuroblastoma.
    Ito R; Asami S; Kagawa S; Motohashi S; Shichino H; Chin M; Yoshida Y; Nemoto N; Mugishima H; Suzuki T
    Biol Pharm Bull; 2004 Mar; 27(3):315-8. PubMed ID: 14993794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential detection of tumor cells in the peripheral blood and bone marrow of patients with stage IV neuroblastoma by the reverse transcription-polymerase chain reaction for tyrosine hydroxylase mRNA.
    Miyajima Y; Horibe K; Fukuda M; Matsumoto K; Numata S; Mori H; Kato K
    Cancer; 1996 Mar; 77(6):1214-9. PubMed ID: 8635146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.
    Kuroda T; Saeki M; Nakano M; Mizutani S
    J Pediatr Surg; 1997 Jan; 32(1):69-72. PubMed ID: 9021573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year.
    Burchill SA; Lewis IJ; Abrams KR; Riley R; Imeson J; Pearson AD; Pinkerton R; Selby P
    J Clin Oncol; 2001 Mar; 19(6):1795-801. PubMed ID: 11251011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients.
    Yáñez Y; Hervás D; Grau E; Oltra S; Pérez G; Palanca S; Bermúdez M; Márquez C; Cañete A; Castel V
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):573-80. PubMed ID: 26498952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma.
    Gilbert J; Norris MD; Marshall GM; Haber M
    Br J Cancer; 1997; 75(12):1779-81. PubMed ID: 9192981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.